Local, federal lawmakers urge NYC hospitals to fight DOJ push for trans youth records
Mount Sinai hospital has informed parents that it intends to comply with a federal subpoena from the Department of Justice, which seeks medical records related to gender-affirming care provided to minors. This development marks a significant escalation in the federal government’s ongoing efforts to obtain patient information from hospital systems across the country regarding services such as puberty blockers and hormone treatments.
Mount Sinai spokesperson Lucia Lee stated that the hospital is committed to safeguarding patient privacy but noted that the facility is required by the New York State Shield law to notify families when such subpoenas are received. The hospital currently plans to produce only de-identified information, with all patient-identifying details removed, should it be required to fulfill the request.
Did You Know? NYU Langone Health was the first hospital system identified as having received a federal criminal subpoena for records concerning gender-affirming care provided to minors.
Congressional and Local Response
The move has drawn sharp criticism from elected officials. Representative Jerry Nadler characterized the federal government’s actions as a “weaponization of the justice system against trans youth,” calling for an immediate end to the targeting of healthcare providers. He emphasized that gender-affirming care is healthcare and that patient privacy remains a fundamental right.
The City Council’s LGBTQIA+ Caucus described the reports as “deeply alarming,” labeling the federal subpoenas part of a coordinated campaign to intimidate families and providers. State Assemblymember Micah Lasher also condemned the federal approach, stating his opposition to the administration’s actions regarding trans youth and their care.
Expert Insight: The intersection of federal criminal subpoenas and state-level privacy protections creates a complex legal landscape. The conflict highlights a broader struggle over the constitutional right to privacy versus federal investigative authority, with the outcome likely to set significant precedents for how medical institutions handle sensitive patient data in the face of national policy shifts.
Legal Challenges and Future Implications
A class-action lawsuit has been filed by a group of trans New Yorkers against both NYU Langone and the Department of Justice. The suit challenges the constitutionality of the subpoenas and seeks to block the release of health information. While NYU Langone was initially given until June 10 to respond to its subpoena, a federal judge has extended that deadline to at least June 24.
Looking ahead, the legal battle over these records may continue to unfold as hospitals navigate competing federal demands and state-level protections. If other hospitals receive similar subpoenas, further litigation could be expected to test the limits of federal investigative power against established patient privacy rights. The City Council is also scheduled to hold an oversight hearing on access to gender-affirming care later this month, which may provide further clarity on the local response to these federal interventions.
Frequently Asked Questions
What kind of medical records is the Department of Justice seeking?
The subpoenas seek medical records and other documents related to gender-affirming care provided to minors, including services such as puberty blockers and hormone treatments.
How has Mount Sinai responded to the subpoena?
Mount Sinai has stated it is committed to patient privacy and plans to provide only de-identified information, with all patient-identifying details removed, if it is ultimately required to produce the records.
What is the status of the legal challenge against these subpoenas?
A class-action lawsuit has been filed to challenge the constitutionality of the subpoenas and to block the release of health information. A federal judge has also extended the deadline for NYU Langone to respond to its subpoena until at least June 24.
How do you believe the balance between federal investigations and patient privacy rights should be managed in the current legal climate?